Health Insurance News 6 October 2025

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

In summary, Humana Inc. faces a pivotal moment: it’s balancing short-term earnings headwinds from elevated costs and rating setbacks against strong long-term fundamentals in the Medicare Advantage space. The latest news (Q3 beat and improved membership outlook) provides some relief

5 November 2025

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) Premarket: Analysts Bullish on Comeback Despite 2025 Woes – What to Watch Nov. 3, 2025

UnitedHealth’s volatile 2025 has made UNH a headline story heading into Nov. 3 trading. After a surprise earnings miss in Q1 and a CEO shakeup this spring, UNH plunged to four-year lows. In late Oct. the turnaround narrative got a boost:

2 November 2025

Analyst Ratings · Financial News · Health Insurance · Investment Strategies · Stock Market

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

CI Stock Price and Recent Trend Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the

30 October 2025

Earnings Reports · Health Insurance · Investment Analysis · Pharmaceutical Industry · Stock Market

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Earnings Beat Drives Stock Higher Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predicted investing.com. Likewise, revenue for the

21 October 2025

Earnings Reports · Financial News · Health Insurance · Investment Strategies · NYSE:ELV · Stock Market

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: – Oscar Health (NYSE: OSCR) shares have surged in early October 2025, recently trading around $21–22 (up ~40% YTD) ts2.tech marketbeat.com. The stock hit about $21.50 on Oct 3 (+11% on the day) and was trading near $21.76

17 October 2025

ACA Policy · Artificial Intelligence · Health Insurance · Investment Analysis · NYSE:OSCR · Stock Market

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets on ACA Hopes and Tech-Driven Growth – Can the Insurtech Finally Turn a Profit?

Financial Performance & Q2 2025 Results Oscar Health’s Q2 2025 results showed rapidly growing revenue but steep losses. Revenue was $2.86 billion, up ~29% from $2.22 billion a year earlier beckerspayer.com. This growth stemmed largely from higher membership – Oscar served over

6 October 2025

Affordable Care Act · Health Insurance · Insurtech · NYSE:OSCR · Stock Analysis · Technology Growth

Health Insurance News 6 October 2025 - 5 November 2025